Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SRDX - Surmodics, Inc.


IEX Last Trade
39.62
-0.050   -0.126%

Share volume: 181,065
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$39.67
-0.05
-0.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
18%
Profitability 0%
Dept financing 33%
Liquidity 53%
Performance 23%
Company vs Stock growth
vs
Performance
5 Days
-0.20%
1 Month
-4.51%
3 Months
-5.87%
6 Months
21.71%
1 Year
4.68%
2 Year
18.23%
Key data
Stock price
$39.62
P/E Ratio 
-404.15
DAY RANGE
N/A - N/A
EPS 
-$0.10
52 WEEK RANGE
$25.17 - $42.44
52 WEEK CHANGE
$0.09
MARKET CAP 
565.401 M
YIELD 
N/A
SHARES OUTSTANDING 
14.267 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$293,947
AVERAGE 30 VOLUME 
$403,846
Company detail
CEO: Gary Maharaj
Region: US
Website: http://www.surmodics.com/
Employees: 355
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.

Recent news